Home
Search
Subscribe
Henry M. Jackson Foundation for the Advancement of Military Medicine
Advancing Military Medicine
Search Results - vaccine
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Immunogens and
Vaccine
Components Against HIV - (HJF 630-22)
Henry M. Jackson Foundation (HJF) researchers have developed a novel
vaccine
strategy against HIV-1. These vaccine candidates are designed to elicit broadly neutralizing antibodies that could protect against a wide variety of HIV strains. Applications and Advantages Novel vaccine design approach that emulates the diversity observed in HIV-1 infections...
Published: 11/6/2024
|
Updated: 2/7/2024
|
Inventor(s):
Morgane Rolland
,
Eric Lewitus
,
Hongjun Bai
Keywords(s):
Antibody
,
Assay
,
bnAbs
,
CD4
,
Env
,
HIV
,
Vaccine
s
Category(s):
Vaccine
,
Therapeutic
Vaccine
s Against Fentanyl and Fentanyl Analogs - (HJF 561-19)
A technology related to novel fentanyl hapten compounds and their use in the preparation of
vaccine
s against fentanyl and fentanyl analogs is available for licensing. Applications and Advantages Novel compounds for use as vaccines against fentanyl and analogs High immunogenicity that generates fentanyl specific antibodies to reduce its distribution...
Published: 10/17/2024
|
Updated: 3/27/2023
|
Inventor(s):
Gary Matyas
,
Oscar Torres
,
Kenner Rice
,
Eric Bow
,
Agnieszka Sulima
,
Arthur Jacobson
Keywords(s):
Antibody
,
Diagnostics
,
Fentanyl
,
Therapeutics
,
Vaccine
s
Category(s):
Diagnostics
,
Therapeutic
,
Vaccine
Compositions and Methods for Producing Protein
Vaccine
s and Therapeutics - (HJF 165-07)
A technology related to compositions and methods for making protein
vaccine
s or therapeutics is available for licensing from the Henry M. Jackson Foundation (HJF). This invention provides a novel composition that, when cellular extracts or whole cells are irradiated, protects cellular protein structure and function while DNA molecules are broken down....
Published: 11/6/2024
|
Updated: 3/27/2023
|
Inventor(s):
Michael Daly
,
Elena Gaidamakova
,
Vera Matrosova
,
Rodney Levine
,
Nancy Wehr
,
Sandip Datta
,
Ian Myles
,
Cedar Fowler
,
Patricia Valdez
Keywords(s):
Healthcare
,
Prevention
,
Therapeutics
,
Vaccine
s
Category(s):
Radioprotection Technologies
,
Vaccine
,
Therapeutic
Potent ZIKV and DENV neutralizing antibodies induced by ZPIV vaccination - (HJF 508-18)
Researchers at The Henry M. Jackson Foundation (HJF), The Beth Israel Deaconess Medical Center (BIDMC), the Armed Forces Research Institute of Medical Sciences (AFRIMS), and the Walter Reed Army Institute of Research (WRAIR) have identified several monoclonal antibodies (mAbs) with a wide-range of capabilities to precisely neutralize Zika virus (ZIKV)...
Published: 10/17/2024
|
Updated: 1/27/2023
|
Inventor(s):
Shelly Krebs
,
Vincent Dussupt
,
Gina Donofrio
,
Kayvon Modjarrad
,
Nelson Michael
,
Dan Barouch
,
Michael Gordon Joyce
,
Kathryn Stephenson
,
Rajeshwer Sankhala
Keywords(s):
Category(s):
Diagnostics
,
Therapeutic
,
Vaccine
Malaria
Vaccine
- (HJF 474-17)
A novel composition of malaria
vaccine
technology is available for licensing from HJF. A Phase I clinical trial has been completed and results have shown the safety and efficacy of this vaccine composition in humans. Applications and Advantages Novel immunogens and compositions for malaria vaccine Significant clinical efficacy demonstrated in humans Fully...
Published: 11/6/2024
|
Updated: 12/1/2022
|
Inventor(s):
Zoltan Beck
,
Carl Alving
,
Gary Matyas
,
Sheetij Dutta
Keywords(s):
Infectious Disease
,
Malaria
,
Prevention
,
Therapeutics
,
Vaccine
s
Category(s):
Therapeutic
,
Vaccine